Evidence map›Paper›PMID 40947144›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2025

[Expert consensus on the management of off-label use of novel antineoplastic agents].

Pharmaceutical Management Professional Committee of Zhejiang Provincial Hospital Association, Zhejiang Quality Control Center for Hospital Drug Affairs, Clinical Pharmaceutical Management Professional Committee of Shanghai Hospital Association, Hospital Pharmaceutical Management Professional Committee of Jiangsu Provincial Hospital Association, Pharmaceutical Management Professional Committee of Anhui Provincial Hospital Association

Abstract readEnglish AbstractConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pharmaceutical Management Professional Committee of Zhejiang Provincial Hospital Association
Zhejiang Quality Control Center for Hospital Drug Affairs
Clinical Pharmaceutical Management Professional Committee of Shanghai Hospital Association
Hospital Pharmaceutical Management Professional Committee of Jiangsu Provincial Hospital Association
Pharmaceutical Management Professional Committee of Anhui Provincial Hospital Association

Funding

This study was supported by National Natural Science Foundation of China (81971981)
6 · The paper itself

Abstract

To enhance medication safety and rational use, a multidisciplinary expert panel from the Yangtze River Delta region-comprising specialists in pharmacy, clinical medicine, healthcare administration, and evidence-based medicine-was convened to develop this consensus through multiple rounds of Delphi consultation. A management system for the off-label use of novel antineoplastic agents was established, incorporating a tiered management process and a regional information sharing platform. Standardized procedures were implemented to regulate the applications, review, documentation, and dynamic adjustment of off-label use. The regional platform centralizes the collection and evaluation of evidence for off-label usage, facilitating consistent and homogeneous manage-ment across healthcare institutions. The tiered management process and information sharing platform established herein are intended to serve as a practical reference for standardizing the management of off-label use of novel antineoplastic agents in medical institutions.

Indexed as

Antineoplastic AgentsOff-Label UseConsensusEvidence-Based MedicineHumansAntineoplastic AgentsAntineoplastic agentsExpert consensusInformation sharing platformOff-label use management

Identifiers

PMID40947144
PMCPMC12571714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.